Career Advisor

Biotech Sales Career Guide and Counseling

We can help you connect with ministry contacts who can provide more information about biotech sales career streams, and who are knowledgeable about current and future hiring needs and biotech sales career development in these areas. Contact us to find out more about biotech sales career path, biotech sales career planning, biotech sales career assessment and biotech sales career choices. what biotech sales career opportunities may be just around the corner and how you can build a satisfying future.

Question: What is outside sales? How tough is it? I want to eventually get into sales in the biotech field.? What should I expect from the job? How much money could I make for being an average salesperson?

Answer: Right there is the problem #1: "Average salesperson". Don't aim for it. You want to be the best. That is Job#1. Outside sales can be very rewarding and enjoyable. It is very demanding too. Your work as a salesperson is performance oriented and very measurable. Unlike anyother employee in the company your work is monitored at all times. And, for a good reason because if you do not bring business, there is no business to work for. They have to shut the door and everyone goes home. That's it. But if you do your work and bring business, they will literally worship you for it and get rewarded much more than you can expect to make as any other employee in the company. No negative thoughts should creep into your mind. There will be a lot of nay-sayers in the sales department. Just avoid them like plague. Stay focussed and you will do a good job and make a lot of money. Sky is the limit. Because you will be making a lot of money there will be a lot jealous pots who will try to sabotage your work and not cooperate fully. So, you have to use a lot of tact inside the office too. Nobody ever said making money is easy. Good luck.


Biotech Sales Career Information and Opportunities

MYCENAX BIOTECH January Sales Rise 2288.12% (Table) : 4726 TT

Bloomberg
MYCENAX BIOTECH said unconsolidated sales in January rose 2288.12% to NT$2412000 from NT$101000, according to a statement filed to the Taiwan Stock Exchange. (Figures are in thousands of New Taiwan dollars) ...
 

BBC News

GSK banks on better R&D returns in tough times
Reuters
 

APEX BIOTECH January Sales Rise 54.71% (Table) : 1733 TT

Bloomberg
APEX BIOTECH said unconsolidated sales in January rose 54.71% to NT$152330000 from NT$98462000, according to a statement filed to the Taiwan Stock Exchange. (Figures are in thousands of New Taiwan dollars) ...
 

Kapitall Blog (blog)

Biotech Ideas: 5 Undervalued Healthcare Stocks with Strong Sources of ...
Kapitall Blog (blog)
 

Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of ...

MarketWatch (press release)
Dr. He has been involved in founding and funding over 20 biotech companies throughout his career. Dr. He received his Ph.D. from Baylor College of Medicine and MBA from The Wharton School of University of Pennsylvania. Dr. He is an author to more than ...
 

Gilead Sciences, Alexion Lead Surge In Biotech Stocks

Investor's Business Daily
Biogen (BIIB) is also a top biotech, with a Composite Rating of 98. Although Gilead grabbed most of the attention, Alexion and Biogen grabbed new highs Friday, too. Biogen crept past estimates for Q4 earnings and sales Tuesday.
 

Kansas City Star

Amgen's 4Q profit falls 9 pct on higher costs, taxes, though biotech giant's ...
Washington Post
 

Model N Launches Powerful Revenue Management BI Solutions for Life Sciences ...

San Francisco Chronicle (press release)
As part of the launch, Model N also announced the acquisition of LeapFrogRx, a pioneer and emerging leader in industry BI solutions for Pharma and Biotech. Founded in 2002, LeapFrogRx has strong capabilities in Brand Marketing, Sales Performance and ...
 

TAIYEN BIOTECH C January Sales Fall 23.04% (Table) : 1737 TT

Bloomberg
TAIYEN BIOTECH C said unconsolidated sales in January fell 23.04% to NT$175294000 from NT$227778000, according to a statement filed to the Taiwan Stock Exchange. (Figures are in thousands of New Taiwan dollars) ...
 

BD Pays SDIX $1.2M to Develop a Microbiology Detection Tool

Genetic Engineering News
The agreement also calls for $2.5 million in milestone payments plus royalties on product sales incorporating SDIX' technology. Upon commercialization of this system SDIX and BD will be engaged in a long-term agreement for the supply of antibodies from ...